All People News articles – Page 9
-
News$1.9M grant will help protect newborns from deadly condition
Nursing researchers will distribute training and resources to US health care providers to save infants from necrotizing enterocolitis.
-
NewsSecond round of polio vaccination in the Gaza Strip aims to vaccinate over half a million children
The second round of an emergency polio vaccination campaign is scheduled to start on 14 October 2024 in Gaza, to vaccinate an estimated 591 700 children under ten years of age with a second dose of the novel oral polio vaccine type 2 (nOPV2) vaccine.
-
NewsNew risks raise pandemic threat on a global scale: GPMB warning
A plethora of risks increase the likelihood of new pandemics according to a new report from the Global Preparedness Monitoring Board (GPMB).
-
News$5.6 million grant awarded to target treatments for IBS, Crohn’s and Ulcerative colitis
An “out-of-the-box” study has been awarded a $5.6 million NIH grant to target treatments for IBS, Crohn’s, Ulcerative Colitis and more.
-
NewsBetter use of vaccines could reduce antibiotic use by 2.5 billion doses annually, says WHO
A new report finds that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22% or 2.5 billion defined daily doses globally every year, supporting worldwide efforts to address antimicrobial resistance (AMR).
-
NewsBioengineer awarded $3.4M for project to end polio
Bioengineer Kevin McHugh has been awarded $3.4 million for a project to incorporate protection against poliomyelitis into the combination vaccine that protects against five common and dangerous childhood diseases.
-
NewsApplied Microbiology International’s 2023 Honorary Fellowship goes to Dr Chikwe Ihekweazu
Applied Microbiology International (AMI) is delighted to announce its 2024 Honorary Fellowship goes to Dr Chikwe Ihekweazu, who serves as Deputy Executive Director of the World Health Organization (WHO) Health Emergencies Programme.
-
NewsTrials show common cold medication significantly improved symptoms in less than two days
Applied Biological Laboratories will present results of a clinical trial which showed Biovanta significantly improved common cold symptoms including sore throat, cough, runny nose, congestion, chills, and sneezing in less than two days.
-
NewsFarewell to John Rigarlsford: a giant in biocides
Former AMI president Dr Peter Silley pays tribute to longstanding member and former committee representative John Rigarlsford, who recently passed away following a short illness.
-
NewsExperts propose key criteria to classify prebiotics
A group of eight leading international scientists has developed a comprehensive framework that outlines the criteria for establishing prebiotic status, providing much-needed clarity in this evolving field.
-
NewsThe Democratic Republic of the Congo kicks off mpox vaccination
The Democratic Republic of the Congo today kicked off mpox vaccination, adding a vital measure to complement the ongoing outbreak control efforts to halt the spread of the viral disease and save lives. Source: NIAID Colorized transmission electron micrograph of mpox virus particles (teal) cultivated and purified ...
-
NewsWHO launches global strategic plan to fight rising Aedes-borne arboviral diseases
The World Health Organization (WHO) has launched the Global Strategic Preparedness, Readiness and Response Plan (SPRP) to tackle dengue and other Aedes-borne arboviruses.
-
NewsNSF to invest $5 million to Biofoundries project
The U.S. National Science Foundation and partner agencies in the U.S., Canada, Finland, Japan, the Republic of Korea (ROK), and the United Kingdom have announced funding awards in their Global Centers competition. One of the centers, the Reliable and Scalable Biofoundries for Biomanufacturing and Global Bioeconomy, includes researchers from the ...
-
NewsCentre for Microbial Interactions at Norwich Research Park is launched
The Centre for Microbial Interactions at Norwich Research Park is launched to promote and support ground-breaking research by one of world’s largest communities of microbiologists, with more than 100 microbiology research groups on one site.
-
NewsMarburg virus disease reaches Rwanda for first time with 26 confirmed cases
On 27 September 2024, the Rwanda Ministry of Health announced the confirmation of Marburg virus disease (MVD). Blood samples taken from people showing symptoms were tested by real-time reverse transcription polymerase chain reaction (RT-PCR) at the National Reference Laboratory of the Rwanda Biomedical Center and were positive for Marburg virus. ...
-
News$12 million grant to research how vaccines induce lasting immunity
Researchers have received a $12 million grant to study how vaccines trigger long-lasting immune responses. The work may inform the design of new, more protective vaccines for respiratory viruses, including SARS-CoV-2 and influenza.
-
NewsSwedish research on antibiotic pollution becomes UN declaration after 17 years
In 2007, researchers at the University of Gothenburg, Sweden published the first in a series of studies showing massive pollution with antibiotics from pharmaceutical factories in India. In connection with the ongoing UN General Assembly in New York, a declaration was approved that underlines the risks and calls for measures ...
-
NewsWorld leaders commit to decisive action on antimicrobial resistance
Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR), pledging to cut the estimated 4.95 million human deaths associated with bacterial AMR annually by 10% by 2030.
-
NewsThousands of donkeys vaccinated against rabies
The Donkey Sanctuary is collaborating with local government agencies and partner organisations, to support vaccination programmes in two key communities that rely on donkeys for their livelihoods.
-
NewsEuropean capacity for antibiotic R&D requires long-term funding
The AMR Accelerator projects have called for long-term investments, stressing the need to preserve the European capacity for antibiotic R&D by sustaining the assets, expertise, and research infrastructures required to develop new treatments for drug-resistant infections.